Helicobacter pylori: From art to a science

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 1, 1998, Pages 21-28

  Hunt, R H ^a   Lam, S K ^b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b NONE

Author keywords

Diagnosis; Gastric cancer; Helicobacter pylori; Peptic ulcer; Treatment

Indexed keywords

AMMONIA; AMOXICILLIN; BISMUTH; CARBON 13; CARBON 14; CLARITHROMYCIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; UREA; UREASE;

ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; BREATH ANALYSIS; COST EFFECTIVENESS ANALYSIS; ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOPHYSIOLOGY; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; STOMACH CANCER;

EID: 0031906255     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00540.x     Document Type: Review

References (69)

1. Howden CW. Clinical expressions of Helicobacter pylori infection. Am. J. Med. 1996; 100: S27-34.
2. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-5.
3. Marshall BJ, McGechie DB, Rogers PA, Glancy RG. Pyloric Campylobacter infection and gastroduodenal disease. Med. J. Aust. 1985; 142: 439-44.
4. Marshall BJ. Epidemiology of H. pylori in Western countries. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: Mechanisms to Clinical Cure. Dordrecht: Kluwer Academic Publishers, 1994; 75-84.
5. Hazell SL. H. pylori in developing countries. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: Mechanisms to Clinical Cure. Dordrecht: Kluwer Academic Publishers, 1994; 85-94.
6. Lambert JR, Lin SK. Prevalence/disease correlates of H. pylori. In: Hunt RH, Tytgat GNJ, eds Helicobacter pylori: Mechanisms to Clinical Cure. Dordrecht: Kluwer Academic Publishers, 1994; 95-112.
7. Cave DR. Transmission and epidemiology of Helicobacter pylori. Am. J. Med. 1996; 100: S12-18.
8. Hulten K, Han SW, Enroth H et al. Helicobacter pylori in the drinking water in Peru. Gastroenterology 1996; 110: 1031-5.
9. Luzza F, Imento M, Maletta M et al. Seroepidemiology of H. pylori infection and hepatitis A in a rural area. Evidence against a common mode of transmission. Gut 1996; 39 (Suppl. 2): A81.
10. Grubel P, Hoffman JS, Chong FK et al. Vector potential of houseflies (Musca domestica) for Helicobacter pylori. Gut 1996; 39 (Suppl. 2): A88.
11. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic antral gastritis. Gastroenterology 1988; 94: 33-40.
12. Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
13. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. Lyon, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 1994; 61: 177-241.
14. Dixon MF, Ectors NL. Gastric cancer. Curr. Opin. Gastroenterol. 1995; 11 (Suppl. 1): 38-41.
15. Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
16. Forman D, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. RMJ 1991; 302: 1302-5.
17. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991; 325: 1127-31.
18. Nomura A, Stemmermann GN, Chyou P-H et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 1991; 325: 1132-6.
19. Forman D. The prevalence of Helicobacter pylori infection in gastric cancer. Aliment. Pharmacol. Ther. 1995; 9 (Suppl. 2): 71-6.
20. Hansson L-E, Engstrand L, Nyren O et al. Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098-103.
21. Huang JQ, Sridhar S, Chen Y, Wilkinson J, Hunt RH. Do younger patients with Helicobacter pylori infection have a higher risk of gastric cancer? A meta-analysis of the relationship between Hp seropositivity and gastric cancer. Gastroenterology 1996; 110: A526.
22. Forman D. Helicobacter pylori and gastric cancer. Scand. J. Gastroenterol. 31 (Suppl. 214): 31-3.
23. Mobley HLT. Defining Helicobacter pylori as a pathogen: Strain heterogeneity and virulence. Am. J. Med. 1996; 100: S2-11.
24. Ritter A, Blum B, Emody L et al. tRNA genes and pathogenicity islands: Influence on virulance and metabolic properties of uropathogenic Escherichia coli. Mol. Microbiol. 1995; 17: 109-21.
25. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 1995; 18: 867-76.
26. Ernst PB, Jin Y, Reyes VE, Crowe SE. The role of the local immune response in the pathogenesis of peptic ulcer formation. Scand. J. Gastroenterol. 1994; 29 (Suppl. 205): 22-8.
27. Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand. J. Gastroenterol. 1996; 31 (Suppl. 215): 3-10.
28. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol. Clin. North Am. 1993; 22: 89-104.
29. Uemura N, Mukai T, Okamoto S et al. Helicobacter pylori eradication inhibits the growth of intestinal type of gastric cancer in initial stage. Gastroenterology 1996; 110: A525.
30. Peura DA. Helicobacter pylori and ulcerogenesis. Am. J. Med. 1996; 100: S19-26.
31. Hogan DL, Rapier RC, Dreilinger A et al. Duodenal bicarbonate secretion: Eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology 1996; 110: 705-16.
32. Achord JL. Gastric pepsin and acid secretion in patients with acute and healed duodenal ulcer. Gastroenterology 1981; 81: 15-18.
33. Blaser MF, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995; 55: 562-5.
34. Hansson L-E, Nyren O, Hsing AW et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J. Med. 1996; 335: 242-9.
35. Parsonnet J. Helicobacter pylori in the stomach: A paradox unmasked. N. Engl. J. Med. 1996; 335: 278-80.
36. Cutler AF. Testing for Helicobacter pylori in clinical practice. Am. J. Med. 1996; 100: S35-41.
37. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT. Accuracy of invasive and non-invasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995; 109: 138-41.
38. Dixon M. Helicobacter pylori and peptic ulceration: Histological aspects. J. Gastroenterol. Hepatol. 1991; 6: 125-30.
39. Enroth HE, Engstrand L. Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens. J. Clin. Microbiol. 1995; 33: 2162-5.
40. Xia HX, Windle HJ, Marshall DG, Smyth CJ, Keane CT, O'Morain CA. Recrudescence of Helicobacter pylori after apparently successful eradication: Novel application of randomly amplified polymorphic DNA fingerprinting. Gut 1995; 37: 30-4.
41. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
42. Roggero E, Zucca E, Pinotti G et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann. Intern. Med. 1995; 122: 767-9.
43. Wurzer H, Rodrigo A, Archambault A et al. Short-course treatment with amoxicillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates H. pylori and heals duodenal ulcer. Gut 1996; 39 (Suppl. 2): A38.
44. Gustavson LE, Kaiser JF, Edmonds AL, Locke CS, DeBartolo ML, Schneck DW. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob. Agents Chemother. 1995; 39: 2078-83.
45. Peterson WL, Graham DY, Marshall BJ et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double-blind trial. Am. J. Gastroenterol. 1993; 88: 1860-4.
46. Logan RPH, Bardhan KD, Celestin LR et al. Eradication of H. pylori and prevention of recurrence of duodenal ulcer: A randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment. Pharmacol. Ther. 1995; 9: 417-23.
47. Hunt R, Schwartz H, Fitch D et al. Dual therapy of clarithromycin and omeprazole for treatment of patients with duodenal ulcers associated with H. pylori infection. Gut 1995; 37 (Suppl. 1): A5.
48. Megraud F, Camou-Juncas C, Occhialini A, Birac C. Helicobacter pylori resistance levels to clarithromycin remain stable. Gastroenterology 1996; 110: A983.
49. Hui WM, Lam SK, Ho J et al. The effect of omeprazole on duodenal ulcer associated antral gastritis and Helicobacter pylori. Dig. Dis. Sci. 1991; 36: 577-82.
50. Hunt RH. pH and Hp: Gastric acid secretion and Helicobacter pylori: Implications for ulcer healing and eradication of the organism. Am. J. Gastroenterol. 1993; 88: 481-3.
51. Ching CK, Leung KP, Yung RWH et al. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut 1996; 38: 675-8.
52. Bell GD, Powell K, Burridge SM et al. Experience with 'triple' anti-Helicobacter pylori eradication therapy: Side-effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment. Pharmacol. Ther. 1992; 6: 427-35.
53. Reddy R, Osato M, Gutierrez O et al. Metronidazole resistance is high in Korea and Columbia and appears to be rapidly increasing in the US. Gastroenterology 1996; 110: A238.
54. Adamek RJ, Suerbaum S, Pfaffenbach B et al. Influence of H. pylori resistance to antibiotics on eradication outcome. Gut 1996; 39 (Suppl. 2): A5.
55. Peitz U, Nusch A, Tillenburg B et al. Frequent metronidazole resistance without significant impact on the high cure rate of Helicobacter pylori infection by triple therapy with omeprazole, metronidazole, and clarithromycin. Gastroenterology 1996; 110: A226.
56. Misiewicz JJ, Harris AW, Bardhan KD. One week low-dose triple therapy for eradication of H. pylori: A large multicentre, randomized trial. Gastroenterology 1996; 110: A198.
57. Lamouliatte H, Cayla R, Talbi P et al. Randomised study comparing two seven days triple therapies with lansoprazole and low dose clarithromycin plus amoxicillin or tinidazole for Helicobacter pylori eradication. Gastroenterology 1996; 110: A648.
58. Lamouliatte H, Cayla R, Zerbib F et al. Triple therapy with PPI-amoxicillin-clarithromycin for H. pylori eradication: The optimal regimen in 1996. Gastroenterology 1996; 110: A647.
59. Sonnenberg A, Townsend W. Costs of duodenal ulcer therapy with antibiotics. Arch. Intern. Med. 1995; 155: 922-8.
60. O'Brien B, Goeree R, Mohamed A, Hunt RH. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. Arch. Intern. Med. 1995; 155: 1958-64.
61. Vakil N, Fennerty MB. Economic modeling of medical therapy for Helicobacter pylori-related peptic ulcer disease. Am. J. Gastroenterol. 1996; 91: 239-45.
62. Laine LA. Helicobacter pylori and complicated ulcer diseased Am. J. Med. 1996; 100: S52-9.
63. 2 blocker maintenance therapy after peptic ulcer bleeding: A prospective randomized trial. Gastroenterology 1995; 108: A208.
64. O'Morain C, Buckley M. Helicobacter pylori and dyspepsia. Scand. J. Gastroenterol. 1996; 31 (Suppl. 214): 28-30.
65. Armstrong D. Helicobacter pylori infection and dyspepsia. Scand. J. Gastroenterol. 1996; 31 (Suppl. 215): 38-47.
66. Ching CK, Wong BCY, Kowk E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am. J. Gastroenterol. 1996; 91: 949-53.
67. McCarthy C, Patchett S, Collins RM et al. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig. Dis. Sci. 1995; 40: 114-19.
68. Sheu B-Y, Lin C-Y, Lin X-Z et al. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: A prospective controlled assessment. Am. J. Gastroenterol. 1996; 91: 441-7.
69. Cuenca R, Blanchard TG, Czinn SJ et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 1996; 110: 1770-5.